← Back to Influence Map
Entity DossierOrganization
Sandoz
Organization identified through public comments on regulations.gov
pharmaceuticals
Tracked direct giving
$0
Tracked donations to candidate
$0
LDA reported lobbying spend
$50,000
Connections
6
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
HCRHealth Issues
$50KLobbying Firms Retained
S-3$50K
Bills Referenced in Lobbying Filings
PBM
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| commented_on | Centers for Medicare & Medicaid Services | Public comment on CMS-2024-0199: Medicare and Medicaid Programs: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; Quality Reporting Programs, in | Source |
| Employed by | S-3 | Hired S-3 GROUP to lobby on PBM Reform Act | Source |
| Affiliated with | TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) | Sandoz was spun off from Novartis in 2023 | Source |
| Affiliated with | NOVARTIS, INC. | Sandoz was spun off from Novartis in 2023 | Source |
| Lobbied for | Action to Delay Effective Date Consistent With Congressionally Enacted Moratorium | Lobbied on pbm — matched LDA filing topic to Federal Register rule. | Source |
| Lobbied for | Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure; Extension of Comment Period | Lobbied on pbm — matched LDA filing topic to Federal Register rule. | Source |